deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT00309842

Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases

Transplantation of Unrelated Umbilical Cord Blood for Patients With Hematological Diseases With Cyclophosphamide/Fludarabine/Total Body Irradiation Myeloablative Preparative Regimen

Sponsor: Masonic Cancer Center, University of Minnesota

Conditions Acute Lymphocytic Leukemia Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Chronic Myelogenous Leukemia Leukemia Lymphoma MDS Multiple Myeloma Myelodysplastic Syndromes Myelofibrosis Non-Hodgkin's Lymphoma Prolymphocytic Leukemia Refractory Anemia
Interventions cyclophosphamide cyclosporine filgrastim fludarabine phosphate mycophenolate mofetil total-body irradiation umbilical cord blood transplantation
Updated 10 times since 2017 Last updated: Sep 9, 2020 Started: Jul 28, 2005 Primary completion: Jul 29, 2019 Completion: Nov 22, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00309842, this PHASE2 trial focuses on Acute Lymphocytic Leukemia and Acute Myeloid Leukemia and remains completed. Sponsored by Masonic Cancer Center, University of Minnesota, it has been updated 10 times since 2005, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotRecruiting~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshotRecruiting~Oct 2018 – ~Mar 2019 · 5 months · monthly snapshotCompleted~Mar 2019 – ~Jan 2020 · 10 months · monthly snapshotActive Not Recruiting~Jan 2020 – ~Oct 2020 · 9 months · monthly snapshotCompleted~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Oct 2020 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2020 — Oct 2020 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

▶ Show 5 earlier versions

  1. Mar 2019 — Jan 2020 [monthly]

    Active Not Recruiting PHASE2

    Status: Completed → Active Not Recruiting

  2. Oct 2018 — Mar 2019 [monthly]

    Completed PHASE2

    Status: Recruiting → Completed

  3. Jun 2018 — Oct 2018 [monthly]

    Recruiting PHASE2

  4. Feb 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  5. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Jul 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Masonic Cancer Center, University of Minnesota
Data source: Masonic Cancer Center, University of Minnesota

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations